SNU-719 Cells
759,00 CAD$*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
Renseignements généraux
| Description | The SNU-719 cell line is a human gastric carcinoma model established from the primary gastric tumor tissue of an adult male patient in Korea. It belongs to a collection of gastric cancer lines developed to support cancer research in East Asia, where gastric cancer prevalence is particularly high. SNU-719 was derived from a moderately differentiated adenocarcinoma and has demonstrated strong attachment to plastic culture surfaces, growing as a diffuse monolayer. The line was maintained in RPMI-1640 medium supplemented with 10% heat-inactivated fetal bovine serum. Comprehensive biochemical and genetic profiling of SNU-719 revealed expression of carcinoembryonic antigen (CEA) and high levels of tissue polypeptide antigen (TPA) in both supernatant and cell lysate. However, alpha-fetoprotein (aFP) was not detected. Mutation analysis identified alterations in the TP53 gene, although the c-Ki-ras oncogene remained unmutated in this line. These features make SNU-719 a suitable model for studying the molecular mechanisms of gastric adenocarcinoma and for evaluating biomarker expression and therapeutic interventions. Additionally, STR and SNP profiling have confirmed its identity and uniqueness, ensuring the cell line's reliability for in vitro experimentation. |
|---|---|
| Organisme | Human |
| Tissu | Stomach |
| Maladie | tubular adenocarcinoma |
| Synonymes | SNU719, NCI-SNU-719 |
Caractéristiques
| Âge | 53 years |
|---|---|
| Genre | Male |
| Origine ethnique | Korean |
| Morphologie | Epithelial-like |
| Type de cellule | Epithelial |
| Propriétés de croissance | Adherent, monolayer |
Données réglementaires
| Référence | SNU-719 (Cytion catalog number 305636) |
|---|---|
| Niveau de biosécurité | 2 |
| NCBI_Numéro d'identification fiscale | 9606 |
| Cellosaurus - Numéro d'enregistrement | CVCL_5086 |
Données biomoléculaires
| Profil mutationnel | Mutation: CTNNB1, Simple, p.Gly34Val (c.101G>T), Heterozygous; Mutation: MET, Simple, p.Asp153Ala (c.458A>C), Heterozygous; Mutation: NRAS, Simple, p.Gln61Leu (c.182A>T), Homozygous; Mutation: PIK3CA, Simple, p.Pro104Arg (c.311C>G), Heterozygous |
|---|
Manipulation
| Milieu de culture | RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a) |
|---|---|
| Suppléments | Supplement the medium with 10% FBS |
| Réactif de dissociation | Accutase |
| Temps de doublement | 43 hours |
| Repiquage | Remove medium, add fresh 0.25 % trypsin 0.02 % EDTA solution, stand culture flask at 37''''C for 3 to 5 minutes, add culture medium and collect the cells, transfer the medium into 15ml tube, centrifuge, aspirate the medium, resuspend the pellets with culture medium and dispense into the culture flask |
| Renouvellement des fluides | 2 to 3 times per week |
| Milieu de congélation | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Décongélation et culture des cellules |
|
| Atmosphère d'incubation | 37°C, 5% CO2, humidified atmosphere. |
| Conditions d'expédition | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Conditions d'entreposage | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Contrôle de la qualité et analyse moléculaire
| Stérilité | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificat d'analyse (CoA)
| Numéro de lot | Type de certificat | Date | Numéro de catalogue |
|---|---|---|---|
| 305636-191125 | Certificat d'analyse | 15. Jan. 2026 | 305636 |